Alector, Inc. announced the appointment of Neil Berkley as CFO and CBO.
Berkley has been with Alector since March 2024 and played key roles in corporate strategy and finance.
His extensive experience in biotech and leadership qualities make him well-suited for the position.
Leadership Appointment
Neil Berkley appointed CFO and CBO of Alector, bringing over two decades of biotech executive experience.
Mission Commitment
Berkley's appointment reflects Alector's dedication to advancing therapies for neurodegenerative diseases.
Operational Expertise
Berkley's operational and financial acumen will guide Alector through important milestones.
- Neil Berkley's appointment strengthens Alector's leadership team and strategic vision for future growth.
- His background in corporate development and financing aligns with Alector's goals to enhance its pipeline and partnerships.
Neil Berkley's appointment as CFO solidifies Alector's commitment to innovation and progress in combating neurodegenerative diseases.